Pharmacists

Joint CPhA/APhA Statement - Drug Importation Policy

Thu, Feb 28, 2019

The associations’ top concerns center on patient safety and optimal medication use. When pharmacists dispense medications, they review and assess all available health information to ensure that medications are safe and appropriate for their patients. This includes identifying possible drug interactions and other adverse events and communicating and resolving any concerns with the patients’ prescribers.


Canadian pharmacies may only dispense medications prescribed by a Canadian prescriber. “This regulation is in place to protect the safety of patients by ensuring that physicians and pharmacists have established relationships with their patients and knowledge of their medical histories,” said CPhA CEO Glen Doucet. “Recently proposed personal drug importation policies pose additional challenges that have not been contemplated.” Read the full news release or the full joint statement.

 

Return to list

What's New

Membership Matters

The 2019 PAS Membership and Malpractice Renewal is now open. PAS sent out an email last week to members on how they can renew their PAS membership.

More

An Aging Population, Health care and the Role of Pharmacists in Saskatchewan with a National Comparison

The Pharmacy Association of Saskatchewan, in partnership with CPhA, commissions yearly public opinion surveys on public perceptions and attitudes towards pharmacists in Saskatchewan and across Canada.

More

Update on EpiPen® Availability

There is a recent update from Pfizer Canada on EpiPen® and EpiPen Jr® auto-injectors.

More

Joint CPhA/APhA Statement - Drug Importation Policy

The American Pharmacists Association (APhA) and the Canadian Pharmacists Association (CPhA) have issued a joint statement opposing U.S. federal legislation authorizing personal and commercial importation of prescription drugs from Canada.

More
View All